Amyloid-β peptide aggregation and the influence of carbon nanoparticles

被引:16
|
作者
Xi, Wen-Hui [1 ]
Wei, Guang-Hong [1 ]
机构
[1] Fudan Univ, Dept Phys, State Key Lab Surface Phys, Key Lab Computat Phys Sci,Minist Educ, Shanghai 200433, Peoples R China
基金
中国国家自然科学基金;
关键词
Amyloid-beta; oligomerization; carbon nanoparticles; molecular dynamics; MOLECULAR-DYNAMICS SIMULATIONS; ALZHEIMERS-DISEASE; PROTEIN AGGREGATION; FULL-LENGTH; WILD-TYPE; EXPERIMENTAL CONSTRAINTS; A-BETA(16-22) PEPTIDES; COMPUTER-SIMULATIONS; A-BETA(1-42) MONOMER; PARKINSONS-DISEASE;
D O I
10.1088/1674-1056/25/1/018704
中图分类号
O4 [物理学];
学科分类号
0702 ;
摘要
Soluble peptides or proteins can self-aggregate into insoluble, ordered amyloid fibrils under appropriate conditions. These amyloid aggregates are the hallmarks of several human diseases ranging from neurodegenerative disorders to systemic amyloidoses. In this review, we first introduce the common structural features of amyloid fibrils and the amyloid fibrillation kinetics determined from experimental studies. Then, we discuss the structural models of Alzheimer's amyloid-beta (A beta) fibrils derived from solid-state nuclear magnetic resonance spectroscopy. On the computational side, molecular dynamics simulations can provide atomic details of structures and the underlying oligomerization mechanisms. We finally summarize recent progress in atomistic simulation studies on the oligomerization of A beta (including full-length A beta and its fragments) and the influence of carbon nanoparticles.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Pathways of Amyloid-β Aggregation Depend on Oligomer Shape
    Barz, Bogdan
    Liao, Qinghua
    Strodel, Birgit
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2018, 140 (01) : 319 - 327
  • [22] Modeling the Aggregation Propensity and Toxicity of Amyloid-β Variants
    Tiwari, Manish K.
    Kepp, Kasper P.
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 47 (01) : 215 - 229
  • [23] Inhibition of Amyloid-β Aggregation in Alzheimer's Disease
    Wang, Qiuming
    Yu, Xiang
    Li, Lingyan
    Zheng, Jie
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (08) : 1223 - 1243
  • [24] Copper Enhances Amyloid-β Peptide Neurotoxicity and non β-Aggregation: A Series of Experiments Conducted upon Copper-Bound and Copper-Free Amyloid-β Peptide
    Dai, Xueling
    Sun, Yaxuan
    Gao, Zhaolan
    Jiang, Zhaofeng
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2010, 41 (01) : 66 - 73
  • [25] Tau-peptide fragments and their copper(II) complexes: Effects on Amyloid-β aggregation
    Di Natale, Giuseppe
    Bellia, Francesco
    Sciacca, Michele F. M.
    Campagna, Tiziana
    Pappalardo, Giuseppe
    INORGANICA CHIMICA ACTA, 2018, 472 : 82 - 92
  • [26] A brief history of amyloid aggregation simulations
    Fatafta, Hebah
    Khaled, Mohammed
    Kav, Batuhan
    Olubiyi, Olujide O.
    Strodel, Birgit
    WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE, 2024, 14 (01)
  • [27] New mefenamic acid derivative disrupts aggregation of amyloid-β peptide
    Al-Zurfi, Atheer
    Freeman, Sally
    Aojula, Harmesh
    Penny, Jeffrey
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (11) : 2523 - 2524
  • [28] β-Turn mimetic synthetic peptides as amyloid-β aggregation inhibitors
    Deike, Stefanie
    Rothemund, Sven
    Voigt, Bruno
    Samantray, Suman
    Strodel, Birgit
    Binder, Wolfgang H.
    BIOORGANIC CHEMISTRY, 2020, 101
  • [29] Tanshinones Inhibit Amyloid Aggregation by Amyloid-β Peptide, Disaggregate Amyloid Fibrils, and Protect Cultured Cells
    Wang, Qiuming
    Yu, Xiang
    Patal, Kunal
    Hu, Rundong
    Chuang, Steven
    Zhang, Ge
    Zheng, Jie
    ACS CHEMICAL NEUROSCIENCE, 2013, 4 (06): : 1004 - 1015
  • [30] Cotinine Reduces Amyloid-β Aggregation and Improves Memory in Alzheimer's Disease Mice
    Echeverria, Valentina
    Zeitlin, Ross
    Burgess, Sarah
    Patel, Sagar
    Barman, Arghya
    Thakur, Garima
    Mamcarz, Magorzota
    Wang, Li
    Sattelle, David B.
    Kirschner, Daniel A.
    Mori, Takashi
    Leblanc, Roger M.
    Prabhakar, Rajeev
    Arendash, Gary W.
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 24 (04) : 817 - 835